Events

The 1st Immunology & Inflammation (I & I) Conference aims to serve as an international and interactive platform for exchange of ideas and scientific discussion on the…

The Conference “130 Years Institut Pasteur: Celebrating Science” is a key international meeting held at the Institut Pasteur that aims to celebrate the exciting scientific…

News

Une équipe  internationale de chercheurs dirigée par Eric Vivier  et associant l'Inserm, le CNRS et Aix Marseille Université (au sein du Centre d’Immunologie de Marseille-Luminy…

Giovanna CHIMINI "Chevalier dans l'ordre des Palmes Académiques de Aix-Marseille Université"
This award honours members of the academic community, researchers, teachers and…

Pierre Golstein, Inserm Special Prize 2018. This year, Inserm has decided to award a Special Prize to highlight a major discovery made at Inserm, upstream of the works rewarded by…

Un nouvel anticorps "2 en 1" efficace contre le cancer

Monalizumab ouvre de nouvelles perspectives dans le traitement des cancers par immunothérapie

Monali

Une équipe  internationale de chercheurs dirigée par Eric Vivier  et associant l'Inserm, le CNRS et Aix Marseille Université (au sein du Centre d’Immunologie de Marseille-Luminy),
les sociétés Innate Pharma et MedImmune, en collaboration avec l'Assistance publique des Hôpitaux de Marseille, l'Institut Curie, le centre Léon Bérard, Abramson Cancer Center révèle le potentiel de ce nouvel anticorps médicamenteux (de la famille des inhibiteurs de points de contrôle immunitaire) qui, non seulement restaure l’activité anti-cancéreuse des deux principaux lymphocytes tueurs de tumeurs mais augmente aussi l'efficacité de traitements déjà existants. Chez la souris comme chez l'Homme, cet anticorps utilisé en combinaison avec une immunothérapie déjà existante, a permis de stopper l'évolution de la maladie et d'augmenter le taux de survie dans plusieurs types de cancers.
Ces travaux sont publiés dans Cell. 


Bernard MALISSEN awarded by the FRM 2018

BM FRM 2018

©Photo : Olivier Pasquiers

The "Grand Prix" of the Foundation for Medical Research (FRM) was awarded to Bernard MALISSEN, CNRS Research Director, at the Centre d'Immunologie de Marseille-Luminy, in recognition of all his work in the field of immunology and who, during his career, has developed modern experimental immunology in France.

Bernard MALISSEN,
Directeur de recherche de classe exceptionnelle au CNRS

Directeur du Centre d'Immunophénomique (CIPHE)
Dirige aux côtés de Marie Malissen, l'équipe « Dissection génétique de la fonction des lymphocytes T et des cellules dendritiques » au CIML, laboratoire dont il a été le directeur de 1995 à 2005.
Centre d'Immunologie de Marseille-Luminy

CNRS / Inserm / Aix-Marseille Université
 

Yann KERDILES awarded by the CNRS 2018

 

YK

CNRS Bronze medal is awarded to Yann KERDILES, CNRS Research Scientist in the CIML associated team of Eric VIVIER to reward the success of his work which make him a specialist in his field and encourage him to continue his fruitful research underway. The ceremony took place on October 19, 2018 at Marseille

Yann KERDILES
Chargé de recherche CNRS
Centre d’Immunologie de Marseille-Luminy (CIML)

CNRS / Inserm / Aix-Marseille Université
© Sébastien Mailfert/CIML

 

 

Nobel 2018: ahead of the work by James Allison, a discovery of Pierre Golstein's team

 

Pierre Gols

The Nobel Prize awards in Medicine 2018 are based in part on a discovery made in 1987 in the laboratory of Pierre GOLSTEIN, director of research Inserm. It is indeed his team at the Centre d'Immunologie de Marseille-Luminy  that for the first time identified the CTLA-4 protein, now targeted in certain cancer immunotherapy strategies.

A new member of the immunoglobulin superfamily: CTLA-4. Signed by Pierre Golstein and his team at the Centre d'Immunologie de Marseille-Luminy, this article published on July 16, 1987 in the journal Nature has been cited several hundred times in the scientific literature. This publication is also the origin of the works of James Allison rewarded this year by the Nobel Academy.

A new member of the immunoglobulin superfamily-CTLA-4,
Jean-François Brunet, François Denizot, Marie-Françoise Luciani, Magali Roux-Dosseto, Marie Suzan, Marie-Geneviève Mattei & Pierre Golstein. Nature, volume 328, pages 267–270, 1987

What is Immunology

At the crossroads of biology and medicine, immunology is a scientific discipline that focuses on the operating mechanisms of the immune system. Appeared early in the evolution, this system enables living organisms to defend themselves against pathogens or their own components when they are altered. It involves a large number of cells whose capacity for cooperation, recognition and memory are far from having revealed all their secrets.

Vidéos

Discover our close-ups and our video archives.

Enseignement

Thomson Reuters list of highly cited researchers

Pr Eric VIVIER and Dr Bernard MALISSEN have been selected for the Thomson Reuters 2016, 2017 et 2018 lists of Highly Cited Researchers

Marseille Immunopole

The french immunology cluster.